...
首页> 外文期刊>Nutrition, metabolism, and cardiovascular diseases: NMCD >Anthropometric indices of fat distribution and cardiometabolic risk in Parkinson's disease
【24h】

Anthropometric indices of fat distribution and cardiometabolic risk in Parkinson's disease

机译:帕金森氏病的脂肪分布和心脏代谢风险的人体测量指标

获取原文
获取原文并翻译 | 示例
           

摘要

Background & aims: To investigate the association between anthropometric indices of body fat distribution and cardiometabolic risk factors in a population of Parkinson's disease (PD) patients. Methods & results: One hundred and fifty-seven PD patients (57.3% males) were studied measuring: waist circumference (WC), waist-hip ratio (WHR), waist-to-height ratio (WtHR), body fat percentage (BF%) by impedance, fasting glucose, serum lipids. Information was collected also on diabetes, hypertension and metabolic syndrome (MetS). Increased cardiometabolic risk was defined by ≥2 MetS component traits other than abdominal adiposity. In the whole population, prevalence of overweight and obesity were 35.0% and 19.2%, respectively. However, prevalence of MetS and elevated cardiometabolic risk were 14.6% and 18.5%, respectively. Prevalence was similar between genders, with one exception: adverse fat distribution according to WC and WHR was more common in females (P < 0.001). Using a multivariable model (adjustments: age, smoking status and disease duration), indices were highly correlated with BF% in both genders. WC and WtHR were associated with the number of MetS criteria and elevated risk. The only cardiometabolic parameters associated with anthropometric indices were HDL in men and triglycerides in women. After adjusting also for BMI all the associations found with anthropometric indices disappeared. Conclusions: Despite their correlation with BF%, anthropometric indices of body fat distribution appear to poorly account for the reduced cardiometabolic risk of the PD patient. This finding suggests a low metabolic activity within the adipose tissue. The implications of fat distribution on the cardiometabolic risk of PD patients clearly deserves further investigation.
机译:背景与目的:研究人体脂肪分布的人体测量指标与帕金森氏病(PD)患者人群中心脏代谢危险因素之间的关系。方法与结果:研究了157例PD患者(男性占57.3%)的测量指标:腰围(WC),腰臀比(WHR),腰高比(WtHR),体脂百分比(BF) %)通过阻抗,空腹血糖,血清脂质。还收集了有关糖尿病,高血压和代谢综合征(MetS)的信息。除腹部肥胖外,≥2MetS组分性状定义为心脏代谢风险增加。在整个人群中,超重和肥胖的患病率分别为35.0%和19.2%。然而,MetS的患病率和升高的心脏代谢风险分别为14.6%和18.5%。性别的患病率相似,但有一个例外:根据WC和WHR的不良脂肪分布在女性中更为常见(P <0.001)。使用多变量模型(调整:年龄,吸烟状况和疾病持续时间),该指数与男女的BF%高度相关。 WC和WtHR与MetS标准的数量和风险升高相关。唯一与人体测量指标相关的心脏代谢参数是男性的HDL和女性的甘油三酸酯。在还针对BMI进行调整之后,所有与人体测量指标相关的关联都消失了。结论:尽管人体脂肪分布的人体测量指标与BF%相关,但似乎不能很好地解释PD患者降低的心脏代谢风险。该发现表明脂肪组织内的代谢活性低。脂肪分布对PD患者心脏代谢风险的影响显然值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号